Clinical Trial

COLO-PREDICT: Digital Training and Optical Diagnosis of Colorectal Polyps

Study acronym: COLO-PREDICT
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 23, 2026 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
Colorectal cancer prevention relies on high-quality colonoscopy and accurate optical characterization of colorectal polyps. Optical diagnosis may allow optimization of management strategies such as resect-and-discard for diminutive polyps, potentially improving efficiency in routine practice. COLO-PREDICT is a prospective, single-center, observational study designed to evaluate the impact of a structured digital training program (Colo-ID, a digital application for colonic polyp characterisation training) on the accuracy of optical histology prediction of colorectal polyps in real-life clinical practice. All consecutive adult patients undergoing colonoscopy with at least one detected polyp will be included. Optical prediction of polyp histology will be recorded during the procedure. All polyps will be resected and sent for histopathological analysis according to standard practice. No modification of patient management will occur as part of the study. The primary objective is to assess the concordance between optical prediction and histopathology before and after implementation of the digital training program. Secondary objectives include evaluation of prediction performance according to polyp characteristics and assessment of potential implications for clinical practice.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-14.
Trial Details
NCT Number NCT07424391
Lead Sponsor Clinique Paris-Bercy
Conditions Colorectal Polyps
Enrollment 1,500 participants
Start Date 2026-02-09
Primary Completion 2026-06 (estimated)
Study Completion 2026-09 (estimated)
Updated on ClinicalTrials.gov 2026-02-23